TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Boston Scientific Nordic AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
123,203
|
120,929
|
107,424 |
| Financial expenses |
13
|
74
|
41 |
| Earnings before taxes |
3,214
|
3,868
|
2,867 |
| EBITDA |
3,756
|
4,445
|
3,511 |
| Total assets |
43,836
|
39,978
|
37,823 |
| Current assets |
41,868
|
38,070
|
36,136 |
| Current liabilities |
22,382
|
20,575
|
21,019 |
| Equity capital |
21,454
|
19,402
|
16,804 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
136
|
126
|
120 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
48.9%
|
48.5%
|
44.4% |
| Turnover per employee |
906
|
960
|
895 |
| Profit as a percentage of turnover |
2.6%
|
3.2%
|
2.7% |
| Return on assets (ROA) |
7.4%
|
9.9%
|
7.7% |
| Current ratio |
187.1%
|
185.0%
|
171.9% |
| Return on equity (ROE) |
15.0%
|
19.9%
|
17.1% |
| Change turnover |
6,385
|
13,192
|
9,543 |
| Change turnover % |
5%
|
12%
|
10% |
| Chg. No. of employees |
10
|
6
|
7 |
| Chg. No. of employees % |
8%
|
5%
|
6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.